0000950170-24-094079.txt : 20240808 0000950170-24-094079.hdr.sgml : 20240808 20240808163004 ACCESSION NUMBER: 0000950170-24-094079 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240806 FILED AS OF DATE: 20240808 DATE AS OF CHANGE: 20240808 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Basile Edward M CENTRAL INDEX KEY: 0001773661 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38891 FILM NUMBER: 241188932 MAIL ADDRESS: STREET 1: 200 MINUTEMAN ROAD CITY: ANDOVER STATE: MA ZIP: 01810 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TransMedics Group, Inc. CENTRAL INDEX KEY: 0001756262 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 000000000 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 MINUTEMAN ROAD CITY: ANDOVER STATE: MA ZIP: 01810 BUSINESS PHONE: 9785520900 MAIL ADDRESS: STREET 1: 200 MINUTEMAN ROAD CITY: ANDOVER STATE: MA ZIP: 01810 4 1 ownership.xml 4 X0508 4 2024-08-06 0001756262 TransMedics Group, Inc. TMDX 0001773661 Basile Edward M C/O TRANSMEDICS GROUP, INC. 200 MINUTEMAN ROAD ANDOVER MA 01810 true false false false true Common Stock 2024-08-06 4 M false 6750 28.12 A 7482 D Common Stock 2024-08-06 4 S false 1830 148.26 D 5652 D Common Stock 2024-08-06 4 S false 2383 149.71 D 3269 D Common Stock 2024-08-06 4 S false 1000 150.7 D 2269 D Common Stock 2024-08-06 4 S false 1537 151.89 D 732 D Stock Option (Right to Buy) 28.12 2024-08-06 4 M false 6750 0.00 D 2032-06-01 Common Stock 6750 6750 D The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $147.76 to $148.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $149.21 to $150.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $150.50 to $151.09, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $151.80 to $152.19, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The option is fully vested. By: /s/ Stephen Gordon, Attorney-in-Fact 2024-08-08